Hainan Rizhongtian Pharmaceutical Co., Ltd.

Primary objective: To evaluate the bioequivalence of the test preparation, Cefdinir dispersible tablets 100 mg, and the reference preparation, Cefdinir capsules (trade name: Cefzon®) 100 mg, in healthy adult subjects in the fasting and fed state. Secondary objective: To observe the safety of the test preparation and the reference preparation in healthy subjects.

The main purpose of the study was to use the cefixime capsules (100 mg/capsule) produced by Hainan Rizhongtian Pharmaceutical Co., Ltd. as the test preparation, and the cefixime capsules (100 mg/capsule) (trade name: Cefspan®) produced by Changshengtang Pharmaceutical Co., Ltd. as the reference preparation for postprandial bioequivalence test according to the relevant provisions of bioequivalence test. Secondary purpose of the study was to observe the safety of the test preparation and the reference preparation in healthy subjects.

Primary objective: To evaluate the bioequivalence of the test preparation cefixime capsule 100 mg and the reference preparation cefixime capsule (trade name: Cefspan®) 100 mg in healthy adult subjects in the fasting and fed state. Secondary objective: To observe the safety of the test preparation and the reference preparation in healthy subjects.